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The single-breath (SB) method for determining the transfer factor for carbon monoxide (7EO) is of limited value 
for the detection of diffusion disorders on the alveolar level, because the results are influenced by unequal 
distribution of ventilation and diffusion. The rebreathing method (RB) is thought not to be influenced by these 
inequalities. To the authors’ knowledge, no study has measured both TLCORB and 7’rCOSB systematically and 
compared them with regard to the influence of unequal ventilation and diffusion. Therefore, the present study 
measured total lung capacity (TLC) as well as TLCO, both with the RB vital capacity method and the SB method, 
using the same apparatus in 10 healthy subjects and in 35 patients with chronic obstructive pulmonary disease 
(COPD). These patients are known to have increased unequal ventilation and diffusion in comparison with healthy 
subjects. 
In the healthy subjects, a small difference was found between TLC measured with the RB method (TLCRB) 
divided by the predicted value (TLCRB/pred) and TLCSB/pred (mean difference 0.07; s~=O,02); no significant 
difference was found between 7XORB divided by the predicted value of fiCOSB (fiCORB/pred) and 
TLCOSBlpred. In the COPD patients, however, TLCRB/pred was larger than TLCSB/pred (mean difference 0.17; 
s~=O.02) and 7XORBlpred was larger than TLCOSB/pred (mean difference 0.23; SE=@05). Multiple regression 
analysis revealed that in the COPD patients, 54% of the variance of the difference between TLCRBlpred and 
TLCSBlpred, and 76% of the variance of the difference between TLCORBlpred and TLCOSBlpred, were explained 
by parameters related to unequal ventilation and diffusion. 
In 25 of the 35 COPD patients, mCOSB/pred was less than 0.8, whereas in 11 of these 25 patients, TLCORB/pred 
was more than 0.8. This difference was significant (P=O.OOOS). In these 11 patients, the SB measurement resulted in 
the incorrect diagnosis of a diffusion disorder on the alveolar level, The RB method, however, never resulted in the 
diagnosis of a diffusion disorder when jVZOSB/pred was larger than 0.8. 
It is concluded that in a significant number of COPD patients, RCOSB is below the normal range, whereas 
RCORB is not below the normal range. This difference between ltCORB and TLCOSB is related to the combined 
effect of unequal ventilation and diffusion, and is of clinical importance for the detection of a diffusion disorder on 
the alveolar level. 
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Introduction 
The calculation of the transfer factor for carbon monoxide 
(nC0) with the single-breath (SB) method (7KOSB) is 
based on a number of implicit assumptions (1). The most 
important assumption is the homogeneity of ventilation 
and diffusion in the entire lung. Many authors, however, 
have emphasized that this assumption is not correct for 
patients (2-5) or healthy subjects (6). Model studies (779) 
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demonstrate that unequal distribution of ventilation and 
diffusion causes the SB method to underestimate TLC0 on 
the alveolar level. With the rebreathing (RB) method, the 
test gas is distributed more evenly. This means that the 
method is less sensitive to unequal ventilation (10,ll) and 
diffusion (12,13). To the authors’ knowledge no study has 
measured both TLCORB and 7’rCOSB systematically in 
the same individuals and compared them with regard to the 
influence of increased unequal ventilation and diffusion. RB 
and SB measurements reported in various publications are 
based on different computation techniques and different 
populations (1,14). Therefore, they cannot be compared. 
To find out whether RB reduces the inlluence of unequal 
ventilation and diffusion on the measurement of TLC0 to 
a degree which is important for clinical practice, it is 
necessary to measure 7XORB and 7tCOSB with the same 
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apparatus in healthy subjects and in stable patients with a 
wide range of unequal ventilation and diffusion. These 
patients have to be in a stable stage of their disease so that 
duplicate measurements can be made on different days. 
COPD patients without recent exacerbations fulfill these 
requirements. It is possible to separate the effects of 
unequal ventilation and unequal diffusion by the measure- 
ment of total lung capacity (TLC) with the rebreathing 
method (TLCRB) and with the single-breath method 
(TLCSB), because this measurement is influenced only by 
unequal ventilation. Support for the hypothesis that the 
difference between RB and SB measurements is due to 
unequal ventilation and diffusion can be obtained by com- 
paring this difference with lung function parameters that 
relate directly or indirectly to unequal ventilation and 
unequal diffusion. 
Methods and Subjects 
TLCRB, TLCSB, TLCORB and TLCOSB were measured 
with a specially developed apparatus as described pre- 
viously (6). Measurements were performed on subjects 
sitting and at rest, starting from residual volume. The 
test-gas bag was filled until the volume was equal to the 
vital capacity (VC) of the subject, the maximum being 4.8 1 
at BTPS. During the RB measurement, the subject was 
encouraged to empty the bag at inspiration and to exhale 
maximally at expiration (vital capacity RB method). The 
rebreathing time was 33 s. The rebreathing frequency was 
about 25 times per minute. The test gas contained 0.1% CO, 
50% helium (He) and 21% oxygen (0,) in balance with 
nitrogen. 
The authors did not correct for CO back pressure 
because measurement time was 33 s, which is lower than the 
blood recirculation time, and because only two rebreathing 
measurements were made in succession. The minimum 
interval between the measurements was 4 min which is 
enough for He washout (15). The SB method was per- 
formed at TLC. All measurements were made in duplicate. 
When using the SB method, one has to prevent the 
admixture of expiratory gas from anatomical dead space to 
the alveolar sample. Therefore, alveolar gas sampling was 
started after the subject had exhaled 25% of inhaled volume 
(VI) (16). Sampling was ended after the subject had exhaled 
75% of VI. Flow-volume curves were recorded and plethys- 
mographic measurements were made in accordance 
with the recommendations of the European Respiratory 
Society (ERS) (17) using an automated lung function 
system (Master Lab, Jaeger). All predicted values were 
derived from the ERS (17), except for 7XOSB. The 
latter was calculated by multiplying the predicted value 
of the SB Krogh factor (YXOSB divided by TLC) in a 
Dutch population (18) by the predicted value of TLC as 
recommended by the ERS (17). 
nCOSB is considered to be below the normal range if 
TLCOSB/pred is smaller than 0.8. This limit corresponds 
very well with the 5th percentile for TLCOSB (19). The 
latter limit is recommended by the ERS (17). The authors 
considered the predicted value for 7XORB and its normal 
range to be equal to the predicted value for RCOSB and its 
normal range. A summary equation (20) reveals a lower 
predicted value for nCORB than for TLCOSB, but a study 
such as this in which the SB and the RB measurement are 
performed near TLC (21) shows no difference between 
TLCOSB and nCORB nor between the normal ranges of 
TLCOSB and TLCORB. In a previous study (6), the present 
authors found no difference between nCOSB and 
TLCORB at VC either. 
Measurements were performed with 10 healthy subjects 
and 37 outpatients suffering from COPD as defined by the 
American Thoracic Society (22) without recent exacer- 
bation. In COPD patients, emphysema and chronic bron- 
chitis mostly exist in combination (22). Lung function 
tests cannot clearly differentiate between these two 
entities. Therefore, the group of COPD patients was con- 
sidered as a whole. Table 1 (left part) shows the relevant 
individual data for the 10 healthy subjects and the 37 
COPD patients. 
Data Analysis 
The statistical package SPSS/PC+ Advanced Statistics 
Version 4.01 was used to analyse the data. Results for the 
healthy subjects and for the COPD patients were compared 
by means of a multivariate analysis of variance 
(MANOVA). MANOVA includes tests on differences 
between duplicate measurements, between RB and SB and 
between healthy subjects and patients. 
In the COPD patients, multiple regression analysis was 
performed on the difference between TLCRB and TLCSB 
divided by the predicted value (TLCRBlpred-TLCSBlpred) 
as well as on (nCORB/pred-TLCOSB/pred). The indepen- 
dent variables were anthropometric data and lung function 
data as measured with spirometry and plethysmography. 
The reciprocals of some of the parameters were chosen 
as independent variables because the relation between 
these reciprocals and TLCRB/pred-TLCSB/pred and 
TLCORBlpred-TrCOSBIpred was linear, which is a 
necessary condition for multiple regression analysis. 
Results 
Table 1 (right part) shows the results of the measurement 
of TLCORB, TLCOSB, TLCRB and TLCSB. In two 
patients (*), TLCbp was larger than 170% of TLCRB. The 
program Examine (SPSS/PC+ Advanced Statistics Version 
4.01) considered these two measurements to be outliers with 
respect to TLCbp, but not with respect to the values of 
7’rCORB, TLCOSB, TLCRB and TLCSB. These two 
patients were excluded from the analysis, which then 
focused on the remaining 35 patients as TLCbp was used as 
an independent variable in the multiple regression analysis 
performed on the difference between TLCRB/pred and 
TLCSBlpred as well as on the difference between 7tCORB/ 
pred and TrCOSBlpred. The possible causes of the large 
difference between TLCbp and TLCRB will be discussed 
below. 
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TABLE 1. Data for the healthy subjects and the chronic obstructive pulmonary disease (COPD) patients 
Subject no. Age Sex Height VC FEV, TLCbp TLCRB TLCSB TLCORB TLCOSB 
Healthy 1 59 m 1.68 4-90 3.76 7.31 7.30 6.73 8.43 8.51 
2 37 m 1.67 4.87 3.54 6.58 7.13 6.54 8.75 8.62 
3 52 m 1.76 4.67 2.85 7.97 8.94 7.99 10.44 9.48 
4 61 m 1.80 4.24 3.12 6.33 6.51 5.86 9.01 9.72 
5 25 f 1.69 3.86 2.78 6.28 5.67 5.05 7.65 7.02 
6 38 m 1.80 5.17 4.16 7.91 7.95 7.63 10.97 11.46 
I 29 m 1.78 465 4.43 6.39 6.23 5.96 8.69 9.19 
8 25 f 1.61 3.62 3.08 4.94 4.90 4.71 8.01 9.19 
9 58 f 1.64 3.17 2.68 4.41 4.78 4.84 6.62 7.29 
10 53 m 1.73 3.81 3.03 5.43 5.71 5.42 7.72 8.47 
Patients 1 48 m 1.71 3.54 2.55 6.42 5.50 4.93 8.24 8.33 
(COPD) 2 69 m 1.86 3.26 0.99 8.33 7.91 5.91 6.67 3.44 
3 55 m 1.87 4.04 3.03 7.70 7.06 6.00 8.95 7.14 
4 53 f 1.69 2.18 1.62 5.21 4.84 4.46 7.21 7.57 
5 66 m 1.84 3.76 1.52 9.16 8.99 7.21 6.59 4.38 
6 73 m 1.61 2.46 0.98 6.80 6.14 4.93 4.71 2.50 
7 53 m 1.78 3.56 1.44 9.33 6.43 5.16 8.88 6.68 
8 57 m 1.82 3.07 1.35 6.89 6.08 4.63 7.54 4.61 
9 64 m 1.78 2.42 0.73 8.07 7.21 5.62 8.07 3.48 
10 66 m 1.84 3.77 1.87 8.05 7.74 6.89 9.19 6.93 
11 20 f 1.80 3.35 2.24 6.66 5.52 5.08 8.52 10.33 
12 66 m 1.67 1.95 0.66 7.44 5.74 4.16 8.75 4.08 
13 58 f 1.67 2.09 0.89 7.34 6.87 5.63 5.59 1.17 
14* 54 m 1.76 2.93 1.44 10.53 6.19 4.80 7.28 5.79 
15 42 m 1.70 4.28 2.71 7.55 7.40 6.94 10.22 11.60 
16 47 f 1.73 1.70 0.90 6.38 5.41 3.76 8.83 6.37 
17 46 m 1.87 4.19 1.86 7.90 7.57 6.63 14.34 13.69 
18 58 m 1.78 2.40 0.72 7.88 6.95 4.44 9.26 3.69 
19 60 f 1.68 1.49 0.62 4.67 3.82 3.07 4.97 3.27 
20 64 m 1.72 1.89 0.81 6.37 5.45 4.02 7.65 4.34 
21 29 m 1.71 3.66 1.96 6.78 6.87 5.59 10.28 10.86 
22 67 m 1.68 3.51 2.13 6.42 6.08 4.68 5.37 3.32 
23 62 f 1.69 3.37 1.90 6.89 6.79 5.67 9.26 7.23 
24 33 m 1.73 5.02 2.33 9.29 7.97 7.08 14.68 11.77 
25 51 m 1.87 4.16 2.82 7.80 7.91 7.08 8.39 7.93 
26 28 m 1.75 3.89 2.21 7.49 7.57 7.27 14.10 14.82 
27 72 m 1.70 3.14 1.16 5.64 6.11 5.25 3.50 2.20 
28 48 m 1.90 4.86 3.22 9.81 9.36 8.84 8.35 6.81 
29 65 m 1.75 2.33 0.89 7.17 6.50 4.73 9.28 4.60 
30 64 m 1.68 2.30 0.60 7.59 6.76 4.68 7.33 3.68 
31 53 m 1.75 3.73 1.69 9.01 7.62 5.94 9.03 5.82 
32 26 m 1.78 5.20 2.99 7.64 7.39 6.52 12.60 11.40 
33 39 m 1.70 3.54 2.09 7.05 6.33 5.51 5.80 4.74 
34* 69 m 1.88 3.12 0.93 11.64 6.38 4.73 4.60 1.54 
35 48 f 1.68 2.75 0.81 7.80 5.40 4.82 4.80 1.40 
36 66 m 1.65 2.98 1.41 8.09 6.95 5.72 5.87 2.66 
37 50 m 1.68 3.09 2.03 5.77 6.01 5.23 7.13 4.95 
For abbreviations see text. Age in years; height in metres; VC, FEV,, TLCRB and TLCSB in litres; TtCORB and RCOSB 
in mmolmin-‘kPaa’. 
Duplicate measurements were available for 44 of the 45 TLC (P=O.36) and TLCO (P=O.29). Therefore, further 
subjects. A MANOVA revealed no difference between the analysis was restricted to the first measurement for all 45 
first measurements and the duplicate measurements for subjects (10 healthy subjects and 35 patients with COPD). 
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FIG. 1. TLCRBlpred as a function of TLCSB/pred in 10 
healthy subjects (m), 35 chronic obstructive pulmonary 
disease (COPD) patients (+) and two COPD patients that 
are outliers (0) with respect to TLCbp (see text). A line 
of identity is drawn. 
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FIG. 2. TrCORBlpred as a function of RCOSB/pred in 
10 healthy subjects (W), 35 chronic obstructive pulmonary 
disease (COPD) patients (+) and two COPD patients that 
are outliers (0) with respect to TLCbp (see text). A line 
of identity is drawn. 
Figures 1 and 2 show the results of the measurement of 
TLCRB/pred and TLCSBlpred and of TkCORB/pred and 
TrCOSBlpred in the healthy subjects and the COPD 
patients. Figure 3 shows the individual relation of the 
difference between TLCSB/pred and TLCRBlpred vs the 
difference between TLCOSB/pred and TLCORBlpred. 
A MANOVA on TLCRB/pred and TLCSBlpred 
for healthy subjects and patients revealed a statistically 
significant interaction (P<O.O005) between patients vs 
healthy subjects and between RB vs SB. This interaction 
means (see Table 2) that in patients, TLCSB/pred was 
significantly smaller than TLCRB/pred (mean difference 
0.17; SE=O.O2). In healthy subjects, TLCSB/pred was also 
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FIG. 3. TLCORBlpred-TrCOSBlpred as a function of 
TLCRBlpred-TLCSBlpred in 10 healthy subjects (m), 35 
chronic obstructive pulmonary disease (COPD) patients 
(+) and two COPD patients that are outliers (0) with 
respect to TLCbp (see text). A line of identity is drawn. 
TABLE 2. Average values (standard errors) of TLCRBlpred 
and TLCSB/pred for healthy subjects and chronic ob- 
structive pulmonary disease (COPD) patients, and the 
differences 
TLC/pred RB (SE) SB (SE) RB - SB (SE) 
Normal 1.03 0.96 0.07 (0.02) 
COPD 1.01 0.83 0.17 (0.02) 
Normal - COPD 0.02 (0.05) 0.13 (0.05) 
significantly smaller than TLCRBipred (mean difference 
0.07; s~=O.02) but the difference was significantly smaller 
(mean difference 0.10; s~=OO.03) than in patients. This 
interaction also means that TLCSB/pred in patients was 
significantly smaller than in healthy subjects (mean differ- 
ence 0.13; SE=O.O5), whereas TLCRB/pred was not signifi- 
cantly different in patients and healthy subjects (mean 
difference 0.02; s~=O.05). Multiple regression analysis on 
(TLCRB/pred-TLCSB/pred) in the COPD patients 
revealed that 54% of the variance of this difference was 
explained by (FEVilpred) ~ ’ and by age (Table 4). 
A MANOVA on TrCORBlpred and TLCOSBlpred for 
healthy subjects and patients revealed a statistically signifi- 
cant interaction between patients vs healthy subjects and 
between RB vs SB (PcO.0005). This interaction means (see 
Table 3) that in patients, RCOSBlpred was significantly 
smaller than TLCORBlpred (mean difference 0.23; 
s~=O.05), whereas in healthy subjects, this difference was 
not significant (mean difference 0.04; s~=O.05). This inter- 
action also means that TrCOSB/pred in patients was sig- 
nificantly smaller than in healthy subjects (mean difference 
0.32; SE=O.O9), whereas TLCORBlpred did not differ sig- 
nificantly between patients and healthy subjects (mean 
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TABLE 3. Average values (standard errors) of 7tCORB/ 
pred and 7tCOSB/pred for healthy subjects and chronic 
obstructive pulmonary disease (COPD) subjects, and the 
differences 
TLCOlpred RB (SE) SB (SE) RB - SB (SE) 
Normal 0.92 0.96 - 0.04 (0.05) 
COPD 0.87 0.64 0.23 (0.05) 
Normal - COPD 0.05 (0.09) 0.32 (0.09) 
difference 0.05; s~=O.09). Multiple regression analysis on 
TLCORBlpred-TLCOSB/pred revealed that 76% of the 
variance of this difference was explained by (FEV,/ 
pred) - ‘, age and TLCbp (Table 4). 
In 11 of the 35 COPD patients, TLCOSB/pred was 
smaller than 0.8, whereas 1ZCORBlpred was larger than 
0.8. This difference was significant (P=O.OOOS; McNemar 
test, one-tailed). nCORB/pred, however, was never 
smaller than 0.8 when lZCOSB was larger than 0.8. In 14 
patients, both TLCOSBlpred and nCORB/pred were 
smaller than 0.8. The remaining 10 patients had a 
TLCORBlpred and TrCOSBlpred larger than 0.8. 
Discussion 
The purpose of this study was to investigate the influence of 
increased unequal ventilation and diffusion on TLCOSB. 
Therefore, TLCOSB was compared with TLCORB because 
the RB method is less sensitive to unequal ventilation 
(10,ll) and diffusion (12,13). The steady-state method for 
determining TLC0 is not used in this study because it is also 
sensitive to ventilation and diffusion inequalities (2,23,24). 
The ventilatory component, TLC, was considered 
initially, followed by the combined effect of ventilation and 
diffusion TLCO. 
In the healthy subjects, TLCRB/pred and TLCSB/pred 
were nearly equal. In the COPD patients, TLCRB/pred was 
larger than TLCSB/pred (mean difference 0.17). This differ- 
ence is believed to be related to unequal ventilation (10,25). 
If it is, then one expects to find a relation between this 
difference and lung function parameters relating to unequal 
TABLE 5. Correlation coefficients with one-tailed significan- 
ces for the independent variables of the multiple regression 
equations 
COPD patients (FEV,/pred) - i Age 
TLCbp/pred 
Age 
0.06 (0.4) - 0.05 (0.4) 
0.40 (0.008) 
ventilation. The existence of this relation still has to be 
proved. Therefore, multiple regression analysis was per- 
formed on TLCRB/pred-TLCSB/pred with anthropometric 
and lung function parameters as independent variables. 
This analysis showed that 54% of the variance could be 
explained by (FEV,/pred) - ’ and age. Decreasing FEV,/ 
pred is related to increasing unequal ventilation and is 
predominantly caused by obstruction of the central air- 
ways, as reported by Roberts et al. (11). Increasing age 
causes an additional increase in TLCRB/pred-TLCSB/ 
pred, despite the significant correlation between (FE&/ 
pred) - i and age (Table 5). A possible explanation is that in 
COPD patients, age is related to unequal ventilation due to 
obstruction of the peripheral airways, which is not related 
to FEV,/pred (11). With regard to TACO, no significant 
difference was found between TLCORB/pred and nCOSB/ 
pred in the healthy subjects. This is in agreement with the 
findings of Rose et al. (26) and Jansons et al. (6). In the 
COPD patients, fiCOSB/pred was found to be smaller 
than 7tCORBlpred (mean difference 0.23). This difference 
is larger than the difference between TLCRB/pred and 
TLCSB/pred (0.17) which means that the difference 
between TLCORBlpred and fiCOSB/pred is only partly 
explained by the difference between TLCRB/pred and 
TLCSB/pred. This result is in agreement with the results 
obtained with two-compartment models (8,9) that demon- 
strate the effects of unequal diffusion in combination 
with unequal ventilation. These models show that unequal 
diffusion amplifies the effect that unequal ventilation has on 
the difference between TLCORBlpred and 7tCOSB/pred. 
Multiple regression analysis on 7tCORBlpred-TLCOSBl 
pred in the COPD patients revealed that 76% of the 
variance was explained by (FEV,/pred) - i, age and TLCbpl 
pred. A comparison of the multiple regression equations for 
TABLE 4. Coefficients (standard errors) of the multiple regression equations for TLCRB/pred- 
TLCSB/pred and TLCORBlpred-TLCOSBlpred 
COPD patients 
TLCRB/pred - 
TLCSB/pred 
(SE) 
nCORB/pred - 
??COSB/pred 
(SE) 
(FEV,/pred) - ’ 
Age 
TLCbp/pred 
Constant 
r* 
0.039 (0.009) 0.088 (0.018) 
0.0018 (0.0007) 0.0065 (0.0014) 
0.50 (0.12) 
- 0.02 (0.04) -0-89 (0.15) 
0.54 0.76 
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TLCRB/pred-TLCSB/pred and TtCORBlpred-ZXOSBl 
pred reveals (see Table 4) that the parameters (FEV,I 
pred) - i and age are found in both equations. However, 
their coefficients are larger in the equation for TLCORBl 
pred-TtCOSBlpred. This is in agreement with the above- 
mentioned combined effect of unequal ventilation and 
diffusion. TLCbp/pred, the third independent variable in 
the multiple regression equation for TLCORBlpred- 
TLCOSBlpred, is one of the best correlating lung function 
parameters in emphysema, as determined in histological 
studies (27). TLCbp/pred also correlates significantly with 
the mean lung density in emphysema, as measured with 
computerized tomographic (CT) scanning (28). Therefore, 
it is plausible to attribute the influence that TLCbp/pred 
exerts on the difference between TLCORBlpred and 
TltCOSBlpred to the unequal distribution of diffusion in 
the unequally distended alveolar spaces in emphysema. 
However, in the case of the two patients who were 
excluded from the analysis, TLCbp was much larger 
(> 170%) than TLCRB. Incomplete test gas wash-in (29) is 
not likely to be the cause, because test gas wash-in seemed 
to be complete within the 33 s of the RB measurement as 
judged by eye on the He wash-in curve. However, the 
authors did not check the test gas wash-in with an He 
dilution volume measurement over a longer period. A 
plausible explanation for the large difference between 
TLCbp and TLCRB is that a part of the lung (e.g. bullae) 
was hardly ventilated in these patients. The presence of a 
large amount of abdominal air is another possibility. This 
means that in the two excluded patients, in contrast with 
the 35 patients, TLCbp cannot be used as a measure of 
emphysema for the lung parts that participate in the 
measurement of TLCO. This corresponds with the result of 
the multiple regression analysis performed on the difference 
between TLCORBlpred and nCOSB/pred when the two 
patients are included. In this case; a smaller explained 
percentage of the variance (66% instead of 76%) and a 
smaller coefficient of TLCbplpred (0.30 instead of 0.50) 
were found. Whether or not nCORB is a reliable measure 
for TLC0 in cases such as these two excluded subjects needs 
further investigation. 
As no significant difference was found between the mean 
values of nCORB/pred in healthy subjects and COPD 
patients in this study, this indicates that, on average, 
the increased unequal ventilation and diffusion have no 
influence on the RB measurement. 
The difference between ?XCORB/pred and TLCOSBl 
pred in COPD patients is of practical importance for the 
diagnosis of a diffusion disorder. This is clearly demon- 
strated by the 11 patients whose TLCOSBlpred was less 
than 0.8 but whose TLCORB/pred was larger than 0.8. The 
clinician needs to be aware of this limitation of the SB 
method when he finds a reduced TLCOSB in COPD 
patients. In those cases, an RB measurement should be 
performed to differentiate between an alveolar diffusion 
disorder and unequal distribution of ventilation and diffu- 
sion. It should be noted that in emphysema; there is a 
combination of unequal ventilation and diffusion. Model 
studies (7-9) reveal that a small inequality in the distri- 
bution of diffusion causes a large decrease of TLCOSB/TLC 
if this unequal diffusion is combined with unequal venti- 
lation. This sensitivity to unequal ventilation and diffusion 
is such that the SB method is used for the detection of 
emphysema (30). The RB method, however, does not detect 
unequal distribution of ventilation and diffusion, and there- 
fore is not sensitive for detecting emphysema. The RB 
method detects only diffusion disorders on the alveolar 
level. 
To conclude, in a significant number of COPD patients, 
TLCOSB is below the normal range, whereas TLCORB is 
not below the normal range. This difference between 
TLCORB and ?“rCOSB is related to the combined effect of 
unequal ventilation and diffusion, and is of clinical impor- 
tance for the detection of a diffusion disorder on the 
alveolar level. 
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